These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15264459)

  • 1. Future immunosuppressive agents in solid-organ transplantation.
    Gabardi S; Cerio J
    Prog Transplant; 2004 Jun; 14(2):148-56. PubMed ID: 15264459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model.
    Matsumoto Y; Hof RP
    Transplant Proc; 2002 Nov; 34(7):2891-2. PubMed ID: 12431647
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study.
    Tedesco-Silva H; Szakaly P; Shoker A; Sommerer C; Yoshimura N; Schena FP; Cremer M; Hmissi A; Mayer H; Lang P;
    Transplantation; 2007 Oct; 84(7):885-92. PubMed ID: 17984842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus and FTY720: new approaches to transplant immunosuppression.
    Kahan BD
    Transplant Proc; 2002 Nov; 34(7):2520-2. PubMed ID: 12431509
    [No Abstract]   [Full Text] [Related]  

  • 7. [New immunodepressant drugs for the prevention and control of kidney transplant rejection].
    Segoloni GP
    G Ital Nefrol; 2005; 22(1):3-15. PubMed ID: 15786373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720.
    Wijkstrom M; Kenyon NS; Kirchhof N; Kenyon NM; Mullon C; Lake P; Cottens S; Ricordi C; Hering BJ
    Transplantation; 2004 Mar; 77(6):827-35. PubMed ID: 15077021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus.
    Kahan BD
    Ther Drug Monit; 2002 Feb; 24(1):47-52. PubMed ID: 11805722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY-720 is efficacious in monkey kidney transplantation.
    Quesniaux V; Menninger K; Audet M; Gaschen L; Schuurman HJ
    Transplant Proc; 2001 May; 33(3):2374-5. PubMed ID: 11377564
    [No Abstract]   [Full Text] [Related]  

  • 11. Enteric-coated mycophenolate sodium.
    Gabardi S; Tran JL; Clarkson MR
    Ann Pharmacother; 2003 Nov; 37(11):1685-93. PubMed ID: 14565799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study.
    Tedesco-Silva H; Lorber MI; Foster CE; Sollinger HW; Mendez R; Carvalho DB; Shapiro R; Rajagopalan PR; Mayer H; Slade J; Kahan BD;
    Clin Transplant; 2009; 23(5):589-99. PubMed ID: 19719728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720: a new immunosuppressive agent with novel mechanism(s) of action.
    Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2210-3. PubMed ID: 9723444
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720: mechanisms of action and its effect on organ transplantation (review).
    Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2779-82. PubMed ID: 10578288
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
    Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
    Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of commonly used immunosuppressive drugs on the small bowel functions - a comparative experimental study.
    Malinowski M; Martus P; Neuhaus P; Stockmann M
    Ann Transplant; 2009; 14(2):38-44. PubMed ID: 19487793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
    Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y
    Transplantation; 2005 Jun; 79(11):1553-60. PubMed ID: 15940045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.
    Tedesco-Silva H; Pescovitz MD; Cibrik D; Rees MA; Mulgaonkar S; Kahan BD; Gugliuzza KK; Rajagopalan PR; Esmeraldo Rde M; Lord H; Salvadori M; Slade JM;
    Transplantation; 2006 Dec; 82(12):1689-97. PubMed ID: 17198261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteric-coated mycophenolate sodium versus mycophenolate mofetil maintenance immunosuppression: outcomes analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network database.
    Irish W; Arcona S; Gifford RJ; Baillie GM; Cooper M
    Transplantation; 2010 Jul; 90(1):23-30. PubMed ID: 20445488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.